4 | SEC Filings Hub

Filing metadata

Accession number: 0000950170-25-088166
Form type: Form 4
Filer: Damora Therapeutics, Inc.
CIK: CIK 1800315
Filed: Jun 20, 2025
Reporting period: Jun 18, 2025
Description: Insider transaction

Documents

0000950170-25-088166-index.htm

Complete submission

0000950170-25-088166.txt

directory listing

Filed by

Damora Therapeutics, Inc.